Abstract
Myocardial infarction constitutes an important health-related problem worldwide. Despite current treatments that salvage myocardial tissue and unload the left ventricle, chronic heart failure is common and is associated with increased morbidity and mortality. During the past decade, experimental studies, using cell-based therapies and growth factor administration integrated in biomaterial scaffolds, have demonstrated the potential to reduce the infarcted area and to improve regional and global left ventricular function. Some aspects of this rapid progress are reviewed in the present ‘special issue’ and a number of novel approaches are being introduced. This series of articles, contributed by research groups with different expertise, is a small step towards the combined efforts required to address the challenges associated with regenerating the infarcted myocardium.
Current Pharmaceutical Design
Title:Editorial: (Thematic Issue: Novel Strategies for Cardiac Repair Post-Myocardial Infarction)
Volume: 20 Issue: 12
Author(s): Simeon Agathopoulos and Theofilos M Kolettis
Affiliation:
Abstract: Myocardial infarction constitutes an important health-related problem worldwide. Despite current treatments that salvage myocardial tissue and unload the left ventricle, chronic heart failure is common and is associated with increased morbidity and mortality. During the past decade, experimental studies, using cell-based therapies and growth factor administration integrated in biomaterial scaffolds, have demonstrated the potential to reduce the infarcted area and to improve regional and global left ventricular function. Some aspects of this rapid progress are reviewed in the present ‘special issue’ and a number of novel approaches are being introduced. This series of articles, contributed by research groups with different expertise, is a small step towards the combined efforts required to address the challenges associated with regenerating the infarcted myocardium.
Export Options
About this article
Cite this article as:
Agathopoulos Simeon and Kolettis M Theofilos, Editorial: (Thematic Issue: Novel Strategies for Cardiac Repair Post-Myocardial Infarction), Current Pharmaceutical Design 2014; 20 (12) . https://dx.doi.org/10.2174/138161282012140401153832
DOI https://dx.doi.org/10.2174/138161282012140401153832 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
Call for Papers in Thematic Issues
"Tuberculosis Prevention, Diagnosis and Drug Discovery"
The Nobel Prize-winning discoveries of Mycobacterium tuberculosis and streptomycin have enabled an appropriate diagnosis and an effective treatment of tuberculosis (TB). Since then, many newer diagnosis methods and drugs have been saving millions of lives. Despite advances in the past, TB is still a leading cause of infectious disease mortality ...read more
Current Pharmaceutical challenges in the treatment and diagnosis of neurological dysfunctions
Neurological dysfunctions (MND, ALS, MS, PD, AD, HD, ALS, Autism, OCD etc..) present significant challenges in both diagnosis and treatment, often necessitating innovative approaches and therapeutic interventions. This thematic issue aims to explore the current pharmaceutical landscape surrounding neurological disorders, shedding light on the challenges faced by researchers, clinicians, and ...read more
Emerging and re-emerging diseases
Faced with a possible endemic situation of COVID-19, the world has experienced two important phenomena, the emergence of new infectious diseases and/or the resurgence of previously eradicated infectious diseases. Furthermore, the geographic distribution of such diseases has also undergone changes. This context, in turn, may have a strong relationship with ...read more
Melanoma and Non-Melanoma Skin Cancer Treatment: Standard of Care and Recent Advances
In this thematic issue, we aim to provide a standard of care of the diagnosis and treatment of melanoma and non-melanoma skin cancer. The editor will invite authors from different countries who will write review articles of melanoma and non-melanoma skin cancers. The Diagnosis, Staging, Surgical Treatment, Non-Surgical Treatment all ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
G Protein-Coupled Receptor Kinase 2 - a Feedback Regulator of Gq Pathway Signalling
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Etiopathogenesis, Classical Immunotherapy and Innovative Nanotherapeutics for Inflammatory Neurological Disorders
Current Nanoscience Nanocarriers in the Delivery of Hydroxychloroquine to the Respiratory System: An Alternative to COVID-19
Current Drug Delivery The Role of Anaphylatoxins C3a and C5a in Regulating Innate and Adaptive Immune Responses
Inflammation & Allergy - Drug Targets (Discontinued) Interrelationship Between Kidney Function and Percutaneous Mitral Valve Interventions: A Comprehensive Review
Current Cardiology Reviews The Quest for Novel Biomarkers in Early Diagnosis of Diabetic Neuropathy
Current Proteomics Targeted Therapies in Bone Sarcomas
Current Cancer Drug Targets Omecamtiv Mecarbil: A Myosin Motor Activator Agent with Promising Clinical Performance and New in vitro Results
Current Medicinal Chemistry Calcium Channel Blockade and Peroxisome Proliferator Activated Receptor γ Agonism Diminish Cognitive Loss and Preserve Endothelial Function During Diabetes Mellitus
Current Neurovascular Research ADAM17 as a Therapeutic Target in Multiple Diseases
Current Pharmaceutical Design Vasopressin & Oxytocin in Control of the Cardiovascular System: An Updated Review
Current Neuropharmacology Approaches for Administering Chemotherapy in the Intensive Care Unit
Current Drug Safety Cell Sheet-Based Myocardial Tissue Engineering: New Hope for Damaged Heart Rescue
Current Pharmaceutical Design Targeting Cyclooxygenase and Nitric Oxide Pathway Cross-Talk: A New Signal Transduction Pathway for Developing More Effective Anti- Inflammatory Drugs
Current Signal Transduction Therapy Human Urotensin II Promotes Hypertension and Atherosclerotic Cardiovascular Diseases
Current Medicinal Chemistry Getting to the Heart of the Matter: Exploring Opportunities for Gene Therapy Treatment of Dystrophic Cardiomyopathy
Current Gene Therapy COVID-19 and the Challenges of Chemotherapy: The Failure Case of Hydroxychloroquine in the Clinical Treatment of SARS-CoV-2 Infection
Coronaviruses The Entirely Subcutaneous Defibrillator (S-Icd): State of the Art and Selection of the Ideal Candidate
Current Cardiology Reviews Combinatorial Therapies for Cardiac Regeneration
Recent Patents on Regenerative Medicine The STAT3 Inhibitor Stattic Impairs Cardiomyocyte Mitochondrial Function Through Increased Reactive Oxygen Species Formation
Current Pharmaceutical Design